SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on May 24, 2018. The filing serves as a Regulation FD disclosure regarding investor presentation materials titled "Enriching the Lives of the Blind," which were utilized at the 19th Annual B. Riley FBR Institutional Investor Conference on the same date.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of presentation materials rather than a financial statement report.
Material Changes
No material financial changes versus prior periods are detailed in this filing. The document focuses solely on the dissemination of the attached investor presentation.
Guidance, Outlook, and Risks
Management commentary is contained within the attached Exhibit 99.1 (Investor Presentation). The filing explicitly disclaims any obligation to update the presentation materials or reflect events occurring after May 24, 2018. The information in this Item 7.01 and the attached exhibit is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference in another filing.
Key Facts for Investor Verification
- Verify the content of the attached Exhibit 99.1 for specific business outlook and strategic details.
- Note that the presentation materials are not legally "filed" under Section 18 of the Exchange Act.
- Confirm that the company has no obligation to update the information provided in this presentation.
- Check the company's Investor Relations website (http://investors.secondsight.com) for the posted presentation materials.